跳至主要内容
临床试验/NCT04914533
NCT04914533撤回不适用

Exploratory Real-world Study Examining the Effect of the Luminance RED Device on Recurrent Aphthous Ulcer Stomatitis

ProofPilot2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年6月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
ProofPilot
入组人数
60
试验地点
2
主要终点
Change in Visual Analog Pain Scale

研究概览

简要总结

Canker sores, also called aphthous ulcers, are small, shallow lesions that develop on the soft tissues in your mouth or at the base of your gums. Unlike cold sores, canker sores don't occur on the surface of your lips and they aren't contagious. They can be painful, however, and can make eating and talking difficult. Recurrent aphthous ulcer stomatitis (RAS) is characterized by recurrent bouts of solitary or multiple shallow painful ulcers, at intervals of a few months to a few days in patients who are otherwise well.

Low Level Laser Therapy (LLLT) sometimes known as Low Level Light Therapy or Photobiomodulation (PBM) is a low-intensity light therapy. The effect is photochemical not thermal. The light triggers biochemical changes within cells and can be compared to the process of photosynthesis in plants, where the photons are absorbed by cellular photoreceptors, which trigger chemical changes.

The main medical usage of LLLT is for pain and inflammation reduction, promoting the regeneration of different tissues and preventing damage to tissues. With the use of the appropriate power (from 5 to 200mW) and wavelength (600-900nm), the therapy brings anti-inflammatory and analgesic results aiding in wound healing. The mechanism of action of LLLT may be very beneficial in the treatment of oral erosions and ulcers, however, very few studies have been performed on the treatment of RAS with LLLT. There are few reports on accelerated healing in erosive mucocutaneous disorders and they are often presented as a case series rather than large randomized clinical trials. The effects on skin wound healing and periodontal inflammation management with laser biostimulation suggest that this treatment modality may also be useful for oral erosive conditions.

This clinical trial aims to evaluate the effect of the Luminance RED device on the management of RAS.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
  • 18 years and older.
  • Self report canker sore outbreaks once every 30 days or more frequent
  • Understands and is willing, able and likely to comply with all study procedures and restrictions.
  • No previous experience of LLLT.
  • United States resident.
  • Willingness and ability to submit a $49 deposit using a credit card for the device.

排除标准

  • Patients with a known systemic disease that predisposes them to RAS (e.g., Behçet disease) or undergoing systemic treatment for RAS.
  • The presence of a serious medical condition.
  • Currently known to be pregnant or breastfeeding
  • Patients treated with topical or systemic medication for RAS, such as corticosteroid therapy, antibiotics or analgesics during the previous month.

研究组 & 干预措施

Intervention Arm

Experimental

Luminance Red Treatment Arm

干预措施: Luminance RED Low Level Laser Therapy Device (Device)

结局指标

主要结局

Change in Visual Analog Pain Scale

时间窗: Baseline to day 18

daily score of canker sore pain

Change in Eating, drinking, and brushing teeth questionnaire

时间窗: Baseline to day 18

score calculated on daily discomfort with eating, drinking and brushing teath

次要结局

  • Device retention(Day 21)

研究者

发起方
ProofPilot
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验